Design Therapeutics (DSGN)
(Delayed Data from NSDQ)
$4.75 USD
+0.04 (0.85%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $4.76 +0.01 (0.21%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.26 | -11.54% |
Earnings Summary
For their last quarter, Design Therapeutics (DSGN) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.25 per share. This reflects a positive earnings surprise of 16.00%. Look out for DSGN's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 7.14%.
Earnings History
Price & Consensus
Zacks News for DSGN
Design Therapeutics, Inc. (DSGN) Upgraded to Buy: Here's What You Should Know
DSGN: What are Zacks experts saying now?
Zacks Private Portfolio Services